These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12007891)

  • 1. Development of a baculovirus expression system for soluble porcine tumor necrosis factor receptor type I and soluble porcine tumor necrosis factor receptor type I-IgG fusion protein.
    Mwangi SM; Stabel TJ; Kehrli ME
    Vet Immunol Immunopathol; 2002 Jul; 86(3-4):251-4. PubMed ID: 12007891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and expression of porcine recombinant soluble tumor necrosis factor receptor 1.
    Maroushek Boury N; Bosworth BT; Stabel TJ; Kehrli ME; Taylor MJ
    Am J Vet Res; 1998 Oct; 59(10):1317-22. PubMed ID: 9781468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and characterization of a recombinant soluble form of bovine tumor necrosis factor receptor type I.
    Mwangi SM; Stabel J; Lee E; Kehrli ME; Taylor MJ
    Vet Immunol Immunopathol; 2000 Dec; 77(3-4):233-41. PubMed ID: 11137122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cloning, expression and bio-activity assay of chimeric fusion protein sTNFRII-IgG Fc].
    Xu CX; Yao LH; Zu D; Chen AJ; Huang GJ; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(2):178-81. PubMed ID: 12148279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and expression in murine erythroleukemia cells: the soluble forms of the type I and type II tumor necrosis factor receptors fused to an immunogenic affinity tag.
    Newton CR; MacCallum LJ; McPheat W; Carr H; Foster HR; Abbott WM; Needham M; Dinsmore A; Copley CG
    Protein Expr Purif; 1994 Oct; 5(5):449-57. PubMed ID: 7530072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of lymphotoxin (LT alpha) and a soluble dimeric form of its receptor using the baculovirus expression system.
    Crowe PD; VanArsdale TL; Walter BN; Dahms KM; Ware CF
    J Immunol Methods; 1994 Jan; 168(1):79-89. PubMed ID: 8288897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and purification of the murine p75-murine IgG1 fusion protein.
    Kim HY; Renshaw-Gegg LW; Balciunas AM; Kohno T
    J Investig Dermatol Symp Proc; 2007 May; 12(1):48-9. PubMed ID: 17502870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha blockade by a dimeric TNF type I receptor molecule selectively inhibits adaptive immune responses.
    Colagiovanni DB; Suniga MA; Frazier JL; Edwards CK; Fleshner M; McCay JA; White KL; Shopp GM
    Immunopharmacol Immunotoxicol; 2000 Nov; 22(4):627-51. PubMed ID: 11105778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression in Escherichia coli of the death domain of the human p55 tumor necrosis factor receptor.
    De Wilde G; Mertens N; Boone E; De Vreese B; Van Beeumen J; Fiers W; Haegeman G
    Protein Expr Purif; 2001 Nov; 23(2):226-32. PubMed ID: 11676596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
    Ashkenazi A; Marsters SA; Capon DJ; Chamow SM; Figari IS; Pennica D; Goeddel DV; Palladino MA; Smith DH
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10535-9. PubMed ID: 1660140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
    Terlizzese M; Simoni P; Antonetti F
    J Interferon Cytokine Res; 1996 Dec; 16(12):1047-53. PubMed ID: 8974008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha modulates the expression of its p60 receptor and several cytokines in rat tracheal epithelial cells.
    Bader T; Nettesheim P
    J Immunol; 1996 Oct; 157(7):3089-96. PubMed ID: 8816419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant tumor necrosis factor-alpha p80 receptor:Fc fusion protein decreases circulating bioactive tumor necrosis factor-alpha but not lung injury or mortality during immunosuppression-related gram-negative bacteremia.
    Lechner AJ; Johanns CA; Matuschak GM
    J Crit Care; 1997 Mar; 12(1):28-38. PubMed ID: 9075062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors.
    Hale KK; Smith CG; Baker SL; Vanderslice RW; Squires CH; Gleason TM; Tucker KK; Kohno T; Russell DA
    Cytokine; 1995 Jan; 7(1):26-38. PubMed ID: 7749064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a negative dominant mutant of human p55 tumor necrosis factor-receptor inhibits TNF and monocyte-induced activation in porcine aortic endothelial cells.
    Stroka DM; Cooper JT; Brostjan C; Millan MT; Goodman DJ; Wrighton CJ; Bach FH; Ferran C
    Transplant Proc; 1997; 29(1-2):882. PubMed ID: 9123566
    [No Abstract]   [Full Text] [Related]  

  • 17. Triggering of antitumor activity through melanoma-specific transduction of a constitutively active tumor necrosis factor (TNF) R1 chimeric receptor in the absence of TNF-alpha.
    Bazzoni F; Regalia E
    Cancer Res; 2001 Feb; 61(3):1050-7. PubMed ID: 11221832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants.
    Ameloot P; Fiers W; De Bleser P; Ware CF; Vandenabeele P; Brouckaert P
    J Biol Chem; 2001 Oct; 276(40):37426-30. PubMed ID: 11448951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine tumor necrosis factor (TNF) and lymphotoxin (LT) alpha differentially modulate cellular sensitivity to TNF/LT-alpha cytotoxicity in L929 cells.
    Decoster E; Cornelis S; Vanhaesebroeck B; Fiers W
    J Cell Biol; 1998 Dec; 143(7):2057-65. PubMed ID: 9864375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A TNF receptor antagonistic scFv, which is not secreted in mammalian cells, is expressed as a soluble mono- and bivalent scFv derivative in insect cells.
    Brocks B; Rode HJ; Klein M; Gerlach E; Dübel S; Little M; Pfizenmaier K; Moosmayer D
    Immunotechnology; 1997 Oct; 3(3):173-84. PubMed ID: 9358270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.